dexamethasone_matthew_horwoodgetty_images

Repurposed corticosteroid dexamethasone shown to reduce mortality in COVID-19 patients needing respiratory support

June 17, 2020
Research and Development COVID-19, University of Oxford, coronavirus, dexamethasone

The University of Oxford has unveiled exciting new data in the treatment of the novel coronavirus, with a randomised clinical …

covid_cell

Pharmafile.com’s weekly COVID-19 news round-up

June 17, 2020
Research and Development COVID-19, coronavirus, coronavirus roundup

There is a fear of a second wave of coronavirus coming out of China, as the country reported its highest …

HPV vaccine approved by FDA to prevent throat cancer

June 17, 2020
Research and Development HPV, HPV STI, HPV vaccine

The HPV (human papillomavirus) vaccine Gardasil 9 has been approved by the FDA to prevent HPV-related genital tract, agnogenital infections …

sanofi

Sanofi drops €610m on new vaccine research and manufacturing sites in France

June 16, 2020
Manufacturing and Production COVID-19, Sanofi

The coronavirus outbreak has changed the way that the world prioritises healthcare resources, and lay bare just how unprepared many …

bhf

British Heart Foundation funding trial of experimental drug designed to prevent blood clots in coronavirus patients

June 16, 2020
Manufacturing and Production COVID-19, blood clots, coronavirus

The British Heart Foundation is funding a trial for a drug that could prevent life-threatening blood clots that have been …

nz

New Zealand no longer virus free after two new cases come from Britain

June 16, 2020
Manufacturing and Production COVID-19, New Zealand, coronavirus, pandemic

New Zealand has reported its first new case of coronavirus after two COVID-19 positive women arrived in the country from …

sinovac

Sinovac’s COVID-19 vaccine successfully generates immune response at Phase 1/2

June 16, 2020
Manufacturing and Production, Research and Development COVID-19, Sinovac, Vaccine, coronavirus, pharma

As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm …

fda

FDA revokes emergency approval of hydroxychloroquine and chloroquine

June 16, 2020
Manufacturing and Production COVID-19, chloroquine, coronavirus, hydroxychloroquine

The FDA has revoked its emergency approval of hydroxychloroquine and chloroquine due to health risks and a lack of effectiveness …

marc_p2

Mundipharma names Marc Princen as Global Chief Executive Officer

June 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment

Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken …

covid-19-4922384_640

COVID-19: UK and Europe life sciences regulatory developments

June 15, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Sidley Austin, coronavirus, pharma, regulation

Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …

janssen_latest_logo_on_sign_closer

Tremfya’s skin clearance benefit lasts up to four years in plaque psoriasis patients, Janssen says

June 15, 2020
Research and Development, Sales and Marketing Janssen, Tremfya, plaque psoriasis

Janssen has revealed new data on its interleukin (IL)-23 inhibitor Tremfya (guselkumab) at the American Academy of Dermatology (AAD) virtual …

wuhan_citiy

Fear of a coronavirus second wave as China reports highest number of cases in months

June 15, 2020
Sales and Marketing COVID, COVID-19, coronavirus, pandemic

China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food …

az_vaccinessssssssssss

AstraZeneca to supply Europe with 400 million COVID-19 vaccine doses

June 15, 2020
Sales and Marketing COVID, COVID-19, Vaccine, coronavirus

Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …

NICE greenlights Roche’s Rozlytrek for ROS1+ advanced non-small cell lung cancer

June 15, 2020
Sales and Marketing NICE, Roche, Rozlytrek, UK, lung cancer

Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …

mr_robot_cancer

AbbVie’s Venclexta plus azacitidine shows improved survival and remissions rates in leukaemia patients

June 15, 2020
Sales and Marketing AbbVie, leukaemia

AbbVie have announced positive results from its latest Phase 3 clinical trial where Venclexta plus azacitidine improved survival and remission …

shutterstock_138095450

Takeda jettisons non-core portfolio in Asia Pacific to Celltrion for a potential $278 million

June 12, 2020
Medical Communications, Sales and Marketing Takeda, celltrion, pharma, sale

Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January …

vaccinessssss

Moderna to begin testing its COVID-19 vaccine in 30,000 people starting in July

June 12, 2020
Medical Communications COVID-19, coronavirus

Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials. The …

fda2outsideweb

Mylan and Biocon’s Semglee, biosimilar to Sanofi’s Lantus, approved by FDA for type 1 and 2 diabetes

June 12, 2020
Medical Communications, Sales and Marketing FDA, Lantus, Mylan Biocon, Sanofi, Semglee, diabetes

Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …

top_10_image_2_3

Top Ten most popular articles on Pharmafile.com this week

June 12, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing coronavirus, top 10

The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the …

nhs_docttttttt

Coronavirus has caused widespread disruption to cancer care in England

June 12, 2020
Medical Communications COVID-19, coronavirus

Figures show that cancer care in England has faced major disruption due to a big drop in referrals from GPs …

The Gateway to Local Adoption Series

Latest content